Search

Displaying results 7991 - 8000 of 10000 in total
  1. Drug

    Nemazoline

    go.drugbank.com/drugs/DB21115
    Experimental

    Nemazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  2. Drug

    Ebrotidine

    go.drugbank.com/drugs/DB21220
    Experimental

    Ebrotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Ebrotidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  3. Drug

    Aloracetam

    go.drugbank.com/drugs/DB21233
    Experimental

    Aloracetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Aloracetam is a piracetam type amide type nootrope agent.

  4. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    Oxmetidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Oxmetidine is a histamine- H2​-receptor antagonist, cimetidine derivative.

  5. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    Tisolagiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Tisolagiline is a monoamine oxydase (MAO)-inhibitor type B.

  6. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    Mosperafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Mosperafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  7. Drug

    Mivebresib

    go.drugbank.com/drugs/DB21300
    Investigational

    Mivebresib is under investigation in clinical trial NCT04480086 (Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants … The usage of the INN stem '-bresib' in the name indicates that Mivebresib is a inhibitor of the bromodomain and extra-terminal motif (BET) family of bromodomain (BRD) protein, antineoplastic.

  8. Drug

    QRX-411

    go.drugbank.com/drugs/DB17868
    Experimental

    It addresses the underlying cause of Usher syndrome due to the c.7595-2144A>G mutation in the _USH2A_ gene.[L46777] … QRX-411 is a first-in-class RNA-based oligonucleotide designed to restore wild-type USH2A mRNA, leading to the production of the functional USH2A protein.

  9. Drug

    TMC-310911

    go.drugbank.com/drugs/DB15623
    Investigational

    [L12045] It is being investigated for use in HIV-1 infections. … [L12045,A191643] TMC-310911 is currently being investigated, in combination with other HIV therapies and antivirals, as a potential treatment for COVID-19 caused by SARS-CoV-2.[L12012]

  10. Drug

    Amcasertib

    go.drugbank.com/drugs/DB14866
    Investigational

    Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).